Provided by Tiger Trade Technology Pte. Ltd.

TEMA ONCOLOGY ETF

44.64
-0.2048-0.46%
Volume:3K
Turnover:154.39K
Market Cap:216.06M
PE:- -
High:44.88
Open:44.86
Low:44.45
Close:44.84
52wk High:47.00
52wk Low:26.52
Shares:4.84M
Float Shares:4.84M
Volume Ratio:0.94
T/O Rate:0.07%
Dividend:0.02
Dividend Rate:0.04%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Eli Lilly: Calling on Entities That Sellers Use to Conduct Their Illegal Business-Social Media and E-Commerce Platforms

THOMSON REUTERS
·
Aug 12

Eli Lilly - Reports over 14,000 Unlawful Retatrutide Listings in 100 Countries

THOMSON REUTERS
·
Aug 12

U.S. Research Roundup-Cardinal Health, Lumentum Holdings, Public Storage

Reuters
·
Aug 12

Legend Biotech Corporation : TD Cowen Cuts Target Price to $24 from $29

THOMSON REUTERS
·
Aug 12

Eli Lilly SVP Finance & CAO Donald A. Zakrowski Lepas 2.000 Saham Senilai USD 2,37 Juta

Reuters
·
Aug 12

Eli Lilly & Co. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Aug 12

Analysts Offer Insights on Healthcare Companies: Immunic (IMUX), Legend Biotech (LEGN) and Sagimet Biosciences, Inc. Class A (SGMT)

TIPRANKS
·
Aug 12

Rothschild & Co Redburn Adjusts Eli Lilly and Co. PT to $915 From $900, Keeps Neutral Rating

MT Newswires Live
·
Aug 12

Why This Growth Stock Manager Likes Both the AI Trade and Eli Lilly

Morning Star
·
Aug 12

Global Drugmakers Invest Billions to Boost US Presence

Reuters
·
Aug 11

Tango Falls After Wider-than-Expected Quarterly Loss

Reuters
·
Aug 11

Eli Lilly's Foundayo Gains First European Approval, Igniting Global Oral Weight-Loss Drug Battle

Deep News
·
Aug 11

U.S. Stocks on the MOVE-Duke Energy, Sea, Cardinal Health

Reuters
·
Aug 11

GenScript Biotech Announces Legend Biotech Form 6-K for Q2 Ended June 30, 2026

Reuters
·
Aug 11

Truist Raises Revolution Medicines PT on Lung Cancer Pipeline Potential

Reuters
·
Aug 11

Cogent Biosciences, Inc. : Guggenheim Raises Target Price to $52 from $45

THOMSON REUTERS
·
Aug 11

Legend Biotech Rises After Second Quarter Results Beat Estimates

Reuters
·
Aug 11

Legend Biotech Shares Rise 4.1% Premarket After Q2 Revenue Beat

THOMSON REUTERS
·
Aug 11

Legend Biotech Q2 Revenue Beats Estimates on Commercial Expansion

Reuters
·
Aug 11

Legend Biotech Q2 FY26 Turns to Net Income of $33.2 Million; Revenue Rises 51.9% to $387.5 Million Year over Year

Reuters
·
Aug 11